Table 2 Baseline characteristics of study participants by RAR quartile

Age (y)

62 (54, 68)

65(55,71)

67(59,73)

69(61,74)

 < 0.001

Male (n, %)

377 (62.0)

382 (62.6)

391 (64.2)

400 (65.7)

0.541

Hypertension (n, %)

406 (66.8)

414 (67.9)

419 (68.8)

385 (63.2)

0.179

DM (n, %)

152 (25.0)

146 (23.9)

134 (22.0)

131 (21.5)

0.431

CHD (n, %)

403 (66.3)

435 (71.4)

431 (71.0)

461 (75.8)

0.004

AF (n, %)

38 (6.3)

34 (5.6)

66 (10.8)

89 (14.6)

 < 0.001

Smoking (n, %)

211 (34.7)

235 (38.5)

225 (36.9)

245 (40.2)

0.231

Drinking (n, %)

89 (14.6)

86 (14.1)

84 (13.8)

94 (15.4)

0.858

BMI (kg/m²)

24.80 (22.84,27.04)

24.90(22.86,26.74)

24.39(22.45,26.78)

24.03(21.64,26.56)

 < 0.001

WBC (×10⁹/L)

6.49(5.36,7.86)

6.66(5.39,8.18)

6.82(5.42,8.61)

6.89(5.53,8.89)

0.022

Neutrophil (×10⁹/L)

4.02(3.12,5.26)

4.10(3.25,5.55)

4.27(3.25,6.15)

4.42(3.37,6.31)

 < 0.001

TC (mmol/L)

4.58(3.88,5.33)

4.48(3.79,5.14)

4.39(3.70,5.10)

4.11(3.49,4.82)

 < 0.001

TG (mmol/L)

1.68(1.22,2.54)

1.63(1.17,2.27)

1.52(1.11,2.21)

1.29(0.92,1.88)

 < 0.001

HDL-C (mmol/L)

1.11(0.96,1.29)

1.08(0.93,1.27)

1.06(0.94,1.26)

1.04(0.90,1.20)

0.769

LDL-C (mmol/L)

2.93(2.33,3.49)

2.90(2.33,3.42)

2.84(2.24,3.47)

2.60(2.16,3.22)

 < 0.001

RDW (%)

12.05(11.80,12.40)

12.3(12.0,12.7)

12.6(12.3,13.1)

13.2(12.65,13.70)

 < 0.001

Albumin (g/dL)

43.0(41.4,44.7)

39.9(38.6,41.0)

38.0(36.9,39.25)

35.3(33.6,36.8)

 < 0.001